Dorin Richard I, Qiao Zhi George, Bouchonville Matthew, Qualls Clifford R, Schrader Ronald M, Urban Frank K
Medical Service, New Mexico VA Healthcare System, University of New Mexico School of Medicine, Albuquerque, New Mexico 87108.
Departments of Medicine and Biochemistry, University of New Mexico School of Medicine, Albuquerque, New Mexico 87106.
J Endocr Soc. 2017 Jun 1;1(7):945-956. doi: 10.1210/js.2017-00198. eCollection 2017 Jul 1.
In secondary adrenal insufficiency (SAI), chronic deficiency of adrenocorticotropin (ACTH) is believed to result in secondary changes in adrenocortical function, causing an altered dose-response relationship between ACTH concentration and cortisol secretion rate (CSR).
We sought to characterize maximal cortisol secretion rate (CSR) and free cortisol half-life in patients with SAI, compare results with those of age-matched healthy controls, and examine the influence of predictor variables on ACTH-stimulated cortisol concentrations.
CSR was estimated from ACTH (250 μg)stimulated cortisol time-concentration data. Estimates for CSR and free cortisol half-life were obtained for both dexamethasone (DEX) and placebo pretreatment conditions for all subjects.
Single academic medical center.
Patients with SAI (n = 10) compared with age-matched healthy controls (n = 21).
The order of DEX vs placebo pretreatment was randomized and double-blind. Cortisol concentrations were obtained at baseline and at intervals for 120 minutes after ACTH.
CSR and free cortisol half-life were obtained by numerical modeling analysis. Predictors of stimulated cortisol concentrations were evaluated using a multivariate model.
CSR was significantly ( < 0.001) reduced in patients with SAI compared with controls for both placebo (0.17 ± 0.09 vs 0.46 ± 0.14 nM/s) and DEX (0.18 ± 0.13 vs 0.43 ± 0.13 nM/s) conditions. Significant predictors of ACTHstimulated total cortisol concentrations included CSR, free cortisol half-life, and baseline total cortisol, corticosteroid-binding globulin, and albumin concentrations (all < 0.05).
Our finding of significantly decreased CSR confirms that SAI is associated with alterations in the CSR-ACTH dose-response curve. Decreased CSR contributes importantly to the laboratory diagnosis of SAI.
在继发性肾上腺皮质功能减退(SAI)中,促肾上腺皮质激素(ACTH)的慢性缺乏被认为会导致肾上腺皮质功能的继发性改变,从而使ACTH浓度与皮质醇分泌率(CSR)之间的剂量反应关系发生改变。
我们试图描述SAI患者的最大皮质醇分泌率(CSR)和游离皮质醇半衰期,将结果与年龄匹配的健康对照者进行比较,并研究预测变量对ACTH刺激的皮质醇浓度的影响。
根据ACTH(250μg)刺激的皮质醇时间 - 浓度数据估算CSR。对所有受试者在接受地塞米松(DEX)和安慰剂预处理条件下均获得了CSR和游离皮质醇半衰期的估计值。
单一学术医学中心。
SAI患者(n = 10)与年龄匹配的健康对照者(n = 21)。
DEX与安慰剂预处理的顺序是随机且双盲的。在基线以及ACTH注射后120分钟内每隔一段时间获取皮质醇浓度。
通过数值建模分析获得CSR和游离皮质醇半衰期。使用多变量模型评估刺激后皮质醇浓度的预测因素。
在安慰剂(0.17±0.09对0.46±0.14nM/s)和DEX(0.18±0.13对0.43±0.13nM/s)条件下,SAI患者的CSR与对照组相比均显著降低(<0.001)。ACTH刺激的总皮质醇浓度的显著预测因素包括CSR、游离皮质醇半衰期、基线总皮质醇、皮质类固醇结合球蛋白和白蛋白浓度(均<0.05)。
我们发现CSR显著降低证实了SAI与CSR - ACTH剂量反应曲线的改变有关。CSR降低对SAI的实验室诊断有重要作用。